Raymond James Financial’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
Raymond James Financial's BTAL Position: Q2 2026 in Review
Raymond James Financial opened a new position in AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026: 14,720 shares worth $164K. The stake represents ﹤0.01% of the portfolio and ranks #5088 among its holdings. This is a return to the name: Raymond James Financial previously reported a position in BTAL as recently as Q2 2025.
Raymond James Financial first reported a position in BTAL in Q4 2024 and has held it in 3 quarters since. The position peaked at $196K in Q4 2024. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- Raymond James Financial held 14,720 shares of AGF US Market Neutral Anti-Beta Fund worth $164K as of Q2 2026.
- AGF US Market Neutral Anti-Beta Fund was a new Raymond James Financial position in Q2 2026.
- AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5088 holding.
- Raymond James Financial first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2024 and has held it in 3 quarters since.
- Raymond James Financial's AGF US Market Neutral Anti-Beta Fund position peaked at $196K in Q4 2024.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.